Prenetics Global Limited (PRE)
NASDAQ: PRE
· Real-Time Price · USD
5.30
0.07 (1.34%)
At close: May 02, 2025, 12:40 PM
1.34% (1D)
Bid | 5.21 |
Market Cap | 64.75M |
Revenue (ttm) | 25.56M |
Net Income (ttm) | -49.01M |
EPS (ttm) | -3.73 |
PE Ratio (ttm) | -1.42 |
Forward PE | -7.37 |
Analyst | Buy |
Ask | 5.48 |
Volume | 4,001 |
Avg. Volume (20D) | 8,609 |
Open | 5.45 |
Previous Close | 5.23 |
Day's Range | 5.03 - 5.50 |
52-Week Range | 3.10 - 6.99 |
Beta | -0.21 |
About PRE
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Website https://www.prenetics.com
Analyst Forecast
According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 69.81% from the latest price.
Stock Forecasts6 months ago
+19.13%
Prenetics Global shares are trading higher followi...
Unlock content with
Pro Subscription
8 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.

2 years ago · fool.com
Why Prenetics Global Stock Is Skyrocketing TodayThe company announced a key FDA clearance.